Skip to content
OpenCapital
Get started

NeoGenomics NEO Free cash flow

Free cash flow at other companies

Personalis, Inc. logo
Personalis, Inc.PSNL
-$25.67M-25.4%
Natera, Inc. logo
Natera, Inc.NTRA
$18.03M-20.3%
Labcorp Holdings logo
Labcorp HoldingsLH
——
Quest Diagnostics logo
Quest DiagnosticsDGX
——
Guardant Health logo
Guardant HealthGH
——
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
——

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%

Valuation

See full
Market cap$1.68B-21.0%
Enterprise value$1.6B-5.6%
P/S2.3×-0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%—

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Calculated from NeoGenomics’s reported figures.

−$8.1Mnet cash from operating−$5.0Mcapital expenditures=-$13.14M

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's free cash flow?
NeoGenomics (NEO) reported free cash flow of -$13.14M in Q1 2026.
How has NeoGenomics's free cash flow changed year-over-year?
NeoGenomics's free cash flow increased by 56.0% year-over-year, from -$29.83M to -$13.14M.
What is the long-term trend for NeoGenomics's free cash flow?
Over 2 years (2021 to 2024), NeoGenomics's free cash flow has grown at a -38.1% compound annual growth rate (CAGR), from -$90.87M to -$34.85M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.